Multitasking nanovectors for cancer imaging and treatment

"Researchers at Imperial College London and the Chemistry of Condensed Matter laboratory in Paris (CNRS/Collège de France/UPMC)1 have designed and developed gold-silica hybrid nanoparticles, which are proving to be genuine therapeutic "Swiss Army knives". Tested on human cells in culture and in mice, these nanoparticles combine two tumor treatment methods and three imaging techniques. In particular, they are said to have greater drug storage and transport capacity than vectors currently on the market, auguring interesting prospects in oncology. These results were published in the journal PNAS on February 4, 2015."